The accumulation of β-amyloid peptide (Aβ) is considered as one of the hallmark features of AD, and is produced by the degeneration of protein tau; however, it contributes in the process of regulating synaptic scaling and synaptic vesicle release, physiologically [73]. The gene discussed is MAPT; the disease is Alzheimer disease.